secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENZ Therapeutics, Inc. (LENZ)
CIK:        0001815776
Form:       8-K
Filed at:   2024-03-08T23:59:59+00:00
Accession:  0001193125-24-063785
Event type: dividend
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Graphite Bio declares special $1.03/share dividend tied to Lenz merger
----------------------------------------------------------------------

- Special dividend estimated at $1.03 per share, capped at $60M.
- Record date March 18, 2024; payment date March 21, 2024.
- Dividend contingent on closing of merger with Lenz Therapeutics.
- Graphite stockholders vote on merger at special meeting March 14, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815776/000119312524063785/0001193125-24-063785-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815776/000119312524063785/d784350d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-063785

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer